🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
The study is an open-labeled extension study to continue to assess the safe...
Status
Completed
Location
10
Start Date
2012-01
Trial ID
NCT01534403
Treatments Being Tested
The purpose of this study is to determine whether epratuzumab provides effe...
Status
Terminated
Location
Weill Medical College of Cornell/ New York Presbyterian Hospital
Start Date
2004-08
Trial ID
NCT00113802
Treatments Being Tested
The primary objective of the study is assess the safety and tolerability of...
Status
Completed
Location
539
Start Date
2011-07
Trial ID
NCT01408576
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-04
Trial ID
NCT00004084
Treatments Being Tested
The goal of this clinical research study is to learn if transferring the do...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-07
Trial ID
NCT00941928
Treatments Being Tested
The main goal of this study is to improve the outcome of children and adole...
Status
Completed
Location
Australian & New Zealand Childhood Hematology & Oncology Group
Start Date
2014-05
Trial ID
NCT01802814
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and e...
Status
Unknown
Location
Garden State Cancer Center
Start Date
1997-06
Trial ID
NCT00004086
The purpose of the study is to evaluate the safety \& efficacy of Epratuzum...
Status
Terminated
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00111306
Treatments Being Tested
The primary objective of the study is to confirm the clinical efficacy of e...
Status
Completed
Location
069
Start Date
2010-12
Trial ID
NCT01262365
Treatments Being Tested